Overall survival in response to sorafenib with transarterial chemoembolization for BCLC stage B hepatocellular carcinoma: propensity score analysis
2017 ◽
Vol 55
(06)
◽
pp. 498-508
◽
2015 ◽
Vol 26
(8)
◽
pp. 1249-1250
◽
2018 ◽
Vol 29
(8)
◽
pp. 1085-1093
◽
2020 ◽
Vol 43
(7)
◽
pp. 1015-1024
◽
2010 ◽
Vol 194
(3)
◽
pp. 830-837
◽
2011 ◽
Vol 196
(2)
◽
pp. W220-W220
◽
2015 ◽
Vol 21
(15)
◽
pp. 4627-4634
◽